Clinical Trial Update: Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing intravitreal ranibizumab with macular laser photocoagulation for macular edema after branch retinal vein occlusion. The statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Seoul Retina Investigator Group | Conditions: Branch Retinal Vein Occlusion | Phase 3 | Status: UNKNOWN